Fortis Capital Advisors’s Medpace MEDP Stock Holding History

Fortis Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-607	Closed	-$129K	–	716
2022 Q4	$129K	Buy	+607	New	+$121K	0.08%	171

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fortis Capital Advisors's MEDP Position: Q1 2023 in Review

Fortis Capital Advisors sold out of Medpace (MEDP) in Q1 2023, closing a stake of 607 shares — an estimated $129K sold.

Fortis Capital Advisors first reported a position in MEDP in Q4 2022 and held it in 1 quarter. The position peaked at $129K in Q4 2022. 416 funds tracked by Wall St. Rank hold MEDP as of Q1 2023.

Fortis Capital Advisors reported no remaining Medpace position as of Q1 2023 after selling out during the quarter.
Fortis Capital Advisors sold 607 Medpace shares in Q1 2023, an estimated $129K.
Fortis Capital Advisors first reported a position in Medpace in Q4 2022 and held it in 1 quarter.
Fortis Capital Advisors's Medpace position peaked at $129K in Q4 2022.
416 funds tracked by Wall St. Rank held Medpace as of Q1 2023.

Based on Fortis Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.